Preclinical studies using murine HCC models have suggested that targeting the the CCL2–CCR2 and CXCL12–CXCR4 axes may be a useful strategy to prevent tumorigenesis [188,189]. The gene discussed is CXCL12; the disease is hepatocellular carcinoma.